Search results
Found 9668 matches for
Researchers at the MRC Weatherall Institute of Molecular Medicine have recently discovered why a class of cancer drugs is beneficial only in a subset of patients. The results could pave the way for the future development of these drugs, known as PNP-inhibitors, as personalised medicines.
Alain Townsend
FRS FRCP Alain Townsend - Emeritus Professor of Molecular Immunology
Bethan Psaila
MA; MBBS; MRCP; FRCPath; PhD Bethan Psaila - Professor of Haematology
Ahmed Ahmed
MBBCH, MSc, MD, MRCOG, PhD Ahmed Ahmed - Professor of Gynaecological Oncology
Jill Brown
BSc (Hons), Postgraduate Certificate in Clinical Cytogenetics Jill Brown - Research Assistant
Noemi Roy
MBChB; BSc; DPhil; MRCP; FRCPath Noemi Roy - Associate Professor of Molecular Haematology
Andrew Wilkie
MA BM BCh DCH DM FRCP FMedSci FRS Andrew Wilkie - Nuffield Professor of Pathology